...
首页> 外文期刊>Journal of Applied Polymer Science >Controlled release of doxycycline within core/shell poly(epsilon-caprolactone)/poly(ethylene oxide) fibers via coaxial electrospinning
【24h】

Controlled release of doxycycline within core/shell poly(epsilon-caprolactone)/poly(ethylene oxide) fibers via coaxial electrospinning

机译:通过同轴电纺线控制核心/壳聚(ε-己内酯)/聚(环氧乙烷)纤维内的强霉素控制释放

获取原文
获取原文并翻译 | 示例

摘要

The development of fibers with desired drug release properties has gained a high research interest for water-soluble drugs with controlled drug delivery systems obtained by coaxial electrospinning technique. The objective of this study is to achieve the controlled-release of doxycycline hyclate (DOXH) from the fabricated electrospun fibers. In this case, three different electrospun core/shell fibers have been successfully fabricated using this technique and the model drug, DOXH, has been entrapped in the core layers. The results of the structural properties and in vitro release studies have been compared with electrospun monostructural fibers fabricated by conventional electrospinning technique. Scanning electron microscopy and transmission electron microscopy images have proved that the fabricated electrospun fibers have core/shell structures. Fourier transform infrared spectroscopy has shown convenient interaction and compatibility between polymers and the model drug. X-ray diffraction analysis has revealed that all the encapsulated DOXH are transferred into amorphous physical state and lost its crystalline state in the fibers. Moreover, drug release studies have demonstrated that the electrospun core/shell fibers show a better-controlled release than the monostructural fibers. It can be concluded that the fibers obtained by blending hydrophilic and hydrophobic polymers such as poly(epsilon-caprolactone) and poly(ethylene oxide) in both shell and core sides are promising candidate for controlled drug release.
机译:具有所需药物释放性能的纤维的发展已经获得了通过同轴电纺丝技术获得的受控药物递送系统的水溶性药物的高研究兴趣。本研究的目的是实现来自制造的电纺纤维的强霉素杂环(DOXH)的控制释放。在这种情况下,使用该技术成功制造了三种不同的Electrom核/壳纤维,并且模型药物DOXH已被夹在核心层中。将结构性质和体外释放研究的结果与通过常规静电纺丝技术制造的Electurpum单组织纤维进行了比较。扫描电子显微镜和透射电子显微镜图像证明了制造的电纺纤维具有核心/壳结构。傅里叶变换红外光谱显示了聚合物和模型药物之间的方便的相互作用和相容性。 X射线衍射分析表明,所有包封的DOXH将所有包封的DOXH转移到无定形物理状态中并在纤维中丢失其结晶状态。此外,药物释放研究表明,电纺芯/壳纤维显示比单个结构纤维更好控制的释放。可以得出结论,通过在壳体和核心侧混合诸如​​聚(ε-己内酯)和聚(环氧乙烷)的亲水和疏水聚合物而获得的纤维是受控药物释放的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号